Literature DB >> 9017161

Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes.

A D Inglot1, M Janusz, J Lisowski.   

Abstract

A proline-rich polypeptide (PRP), now named colostrinine, molecular weight 18,000, was isolated from ovine colostrum and characterized by Janusz, Lisowski et al. The nonapeptide (NP) which is an active fragment of PRP was obtained by chemical synthesis. In mice, PRP has many regulatory effects on the humoral and cellular immune response. The present paper describes PRP as a cytokine inducer. PRP at concentration of 1-100 micrograms/ml was found to induce production of interferon (IFN) and tumor necrosis factor (TNF) in human peripheral blood leukocytes and in whole blood cultures. The effects were dose related. The identified till now cytokines induced by PRP were IFN-gamma and TNF-alpha but many other cytokines may be stimulated also. NP was considerably less active as the cytokine inducer than the natural PRP. Two volunteers given orally once daily for two to three weeks 100 or 200 micrograms PRP in tablets were found to develop the tolerance of IFN induction and had the modified TNF response. Furthermore, the PRP-treated volunteers showed signs of psycho-stimulation. Taken together our observations suggest that ovine PRP is active in humans and may have therapeutic value as an immunostimulant and/or neurotropic cytokine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9017161

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  7 in total

1.  The alcohol-induced conformational changes in casein micelles: a new challenge for the purification of colostrinin.

Authors:  Marian L Kruzel; Antoni Polanowski; Tadeusz Wilusz; Agata Sokołowska; Magdalena Pacewicz; Renata Bednarz; Jerzy A Georgiades
Journal:  Protein J       Date:  2004-02       Impact factor: 2.371

2.  Towards an understanding of biological role of colostrinin peptides.

Authors:  M L Kruzel; M Janusz; J Lisowski; R V Fischleigh; J A Georgiades
Journal:  J Mol Neurosci       Date:  2001-12       Impact factor: 3.444

Review 3.  Clinical applications of bioactive milk components.

Authors:  David R Hill; David S Newburg
Journal:  Nutr Rev       Date:  2015-07       Impact factor: 7.110

4.  C-Terminal Fragment of Vitellogenin II, a Potential Yolkin Polypeptide Complex Precursor Protein-Heterologous Expression, Purification, and Immunoregulatory Activity.

Authors:  Agnieszka Szmyt; Agnieszka Zabłocka; Józefa Macała; Józefa Chrzanowska; Anna Dąbrowska
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

5.  Bioprospecting keratinous materials.

Authors:  L N Jones; R D Sinclair; J Carver; H Ecroyd; Y Lui; L E Bennett
Journal:  Int J Trichology       Date:  2010-01

6.  Isolation and Characterization of NP-POL Nonapeptide for Possible Therapeutic Use in Parkinson's Disease.

Authors:  Marta Lemieszewska; Antoni Polanowski; Tadeusz Wilusz; Agata Sokołowska; Aleksandra Zambrowicz; Katarzyna Mikołajewicz; Józefa Macała; Joanna Rymaszewska; Agnieszka Zabłocka
Journal:  Oxid Med Cell Longev       Date:  2018-07-18       Impact factor: 6.543

7.  Immunomodulatory activity accompanying chicken egg yolk immunoglobulin Y.

Authors:  A Polanowski; A Zabłocka; A Sosnowska; M Janusz; T Trziszka
Journal:  Poult Sci       Date:  2012-12       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.